Schroder Investment Management Group Decreases Holdings in The Cigna Group (NYSE:CI)

Schroder Investment Management Group decreased its position in The Cigna Group (NYSE:CI - Free Report) by 20.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 329,799 shares of the health services provider's stock after selling 84,928 shares during the quarter. Schroder Investment Management Group owned approximately 0.12% of The Cigna Group worth $91,071,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. TCTC Holdings LLC bought a new position in The Cigna Group in the 4th quarter valued at $25,000. Collier Financial bought a new position in The Cigna Group during the fourth quarter valued at about $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the fourth quarter worth about $34,000. Compagnie Lombard Odier SCmA purchased a new stake in The Cigna Group during the fourth quarter worth about $37,000. Finally, Heck Capital Advisors LLC bought a new stake in The Cigna Group in the fourth quarter worth about $53,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

The Cigna Group Price Performance

NYSE CI traded down $16.43 on Friday, hitting $322.02. The stock had a trading volume of 3,800,885 shares, compared to its average volume of 1,666,803. The firm has a 50-day moving average of $308.72 and a 200-day moving average of $313.00. The company has a market capitalization of $88.13 billion, a price-to-earnings ratio of 26.31, a price-to-earnings-growth ratio of 0.98 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

Remove Ads

The Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the business posted $6.79 EPS. Equities analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, March 20th. Investors of record on Wednesday, March 5th were given a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 1.88%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The ex-dividend date was Wednesday, March 5th. The Cigna Group's dividend payout ratio is 49.35%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CI. StockNews.com raised shares of The Cigna Group from a "buy" rating to a "strong-buy" rating in a research report on Saturday, March 29th. Truist Financial reduced their price objective on The Cigna Group from $390.00 to $375.00 and set a "buy" rating for the company in a report on Tuesday, February 4th. Sanford C. Bernstein lowered The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 target price on the stock. in a research note on Thursday, February 6th. Raymond James reiterated a "strong-buy" rating and set a $360.00 price target (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Finally, Royal Bank of Canada set a $355.00 price objective on The Cigna Group in a research note on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $373.25.

Insider Activity at The Cigna Group

In related news, insider Noelle K. Eder sold 9,944 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $320.00, for a total value of $3,182,080.00. Following the transaction, the insider now owns 13,406 shares of the company's stock, valued at $4,289,920. This represents a 42.59 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani sold 26,527 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,751 shares of company stock valued at $13,603,991 over the last three months. 0.70% of the stock is owned by corporate insiders.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.